Condition

Inflammatory bowel disease

Broader IBD news covering Crohn's disease, ulcerative colitis, research, treatments, monitoring, and patient care.

Page 17 of 17 · 786 articles

RS-1805 by Reistone Biopharma for Crohn’s Disease (Regional Enteritis): Likelihood of Approval
pharmaceutical-technology.com

RS-1805 by Reistone Biopharma for Crohn’s Disease (Regional Enteritis): Likelihood of Approval

Cure8 found this source from pharmaceutical-technology.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. Open the original...

Read Summary
Amelenodor by AbbVie for Crohn’s Disease (Regional Enteritis): Likelihood of Approval
pharmaceutical-technology.com

Amelenodor by AbbVie for Crohn’s Disease (Regional Enteritis): Likelihood of Approval

This notes a new oral investigational drug (Amelenodor/NX-13) in Phase I for Crohn’s and ulcerative colitis and highlights industry predictions about its chances of advancing. People with IBD may want to know about...

Read Summary